Home › Asset managers › Guggenheim › 2025-2026 › Against the board
Two kinds of vote are listed: a board-sponsored proposal Guggenheim voted AGAINST or withheld on, and a shareholder proposal it voted FOR. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
2,658 proposals.
| Company | Meeting | Proposal | Category | On the ballot from | Guggenheim voted | Funds |
|---|---|---|---|---|---|---|
| Weatherford International plc | 2026-06-11 | To agree to a scheme of arrangement under Chapter 1 of Part 9 of the Companies Act 2014, as amended, substantially in the form attached as Annex C to the Proxy Statement, that, once it becomes effective, will result in you owning common stock of Weatherford International Corp Instead of ordinary shares of Weatherford international plc. | Extraordinary Transactions | Board | AGAINST | 6 |
| Weatherford International plc | 2026-06-11 | To approve a capital reduction under sections 84 to 86 of the Companies Act to effect the cancellation of Weatherford-Ireland ordinary shares contemplated by the Scheme of Arrangement. | Capital Structure | Board | AGAINST | 6 |
| Weatherford International plc | 2026-06-11 | To approve the terms of an initial subscription, allotment and issue of one, or more, Weatherford-Ireland ordinary shares to Weatherford International Corp ("Weatherford-US") in connection with the Scheme of Arrangement. | Extraordinary Transactions | Board | AGAINST | 6 |
| Weatherford International plc | 2026-06-11 | To authorize the directors of Weatherford-Ireland to allot and issue further new Weatherford-Ireland ordinary shares to Weatherford-US in connection with the Scheme of Arrangement to be paid up by the application of certain reserves as described in the Scheme of Arrangement. | Extraordinary Transactions | Board | AGAINST | 6 |
| Webster Financial Corporation | 2026-05-26 | To approve, on an advisory (non-binding) basis, the compensation payments that will or may be paid to Webster's named executive officers in connection with the transactions contemplated by the Transaction Agreement (the "compensation proposal"). | Say-on-Pay | Board | AGAINST | 6 |
| Wesbanco, Inc. | 2026-04-15 | To approve an advisory (non-binding) vote on compensation paid to Wesbanco's named executive officers in 2025. | Say-on-Pay | Board | AGAINST | 6 |
| Westlake Corporation | 2026-05-14 | Election of Class I Directors: Catherine T. Chao | Director Elections | Board | WITHHOLD | 6 |
| Westlake Corporation | 2026-05-14 | Election of Class I Directors: Jean-Marc Gilson | Director Elections | Board | WITHHOLD | 6 |
| Wingstop Inc. | 2026-05-21 | Approve, on an advisory basis, the compensation of the Company's named executive officers. | Say-on-Pay | Board | AGAINST | 6 |
| e.l.f. Beauty, Inc. | 2025-08-21 | Election of Directors: Lori Keith | Director Elections | Board | WITHHOLD | 6 |
| iHeartMedia, Inc. | 2026-06-04 | The approval, on an advisory (non-binding) basis, of the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 6 |
| lululemon athletica inc. | 2026-06-25 | Advisory vote to approve the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 6 |
| 3D Systems Corporation | 2026-05-14 | The approval of the amendment and restatement of the 2015 Incentive Plan to increase the number of shares reserved for issuance thereunder by 4,000,000 shares and to extend the term until 2036. | Compensation | Board | AGAINST | 5 |
| 8x8, Inc. | 2025-07-25 | To approve an amendment to the 8x8, Inc.'s 2022 Equity Incentive Plan to increase the number of shares of common stock available for issuance thereunder by 8,500,000 shares. | Compensation | Board | AGAINST | 5 |
| Absci Corporation | 2026-06-04 | The election of the Class II directors nominated by the Board of Directors and named in our Proxy Statement to hold office for a three-year term expiring at our 2029 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified: Prof Sir Menelas Pangalos, Ph.D. | Director Elections | Board | WITHHOLD | 5 |
| Advantage Solutions Inc. | 2026-05-27 | To elect four Class III directors from the nominees described in the proxy statement: Tiffany Han | Director Elections | Board | WITHHOLD | 5 |
| AirSculpt Technologies, Inc. | 2026-05-12 | Election of Directors: Kenneth Higgins | Director Elections | Board | AGAINST | 5 |
| Alector, Inc. | 2026-06-17 | ELECTION OF DIRECTORS: Kristine Yaffe, M.D. | Director Elections | Board | WITHHOLD | 5 |
| Alibaba Group Holding Limited | 2025-09-25 | Approve PricewaterhouseCoopers Zhong Tian LLP and PricewaterhouseCoopers as U.S. and Hong Kong Auditors, Respectively, and Authorize Board to Fix Their Remuneration | Audit-related | Board | AGAINST | 5 |
| Allogene Therapeutics, Inc. | 2026-06-18 | Election of Directors: Deborah Messemer | Director Elections | Board | WITHHOLD | 5 |
| Allogene Therapeutics, Inc. | 2026-06-18 | Election of Directors: Owen Witte, M.D. | Director Elections | Board | WITHHOLD | 5 |
| Allogene Therapeutics, Inc. | 2026-06-18 | Election of Directors: Vicki Sato, Ph.D. | Director Elections | Board | WITHHOLD | 5 |
| Alpha Teknova, Inc. | 2026-06-01 | To elect three (3) Class II directors to serve until the 2029 annual meeting of stockholders and until their successors are duly elected and qualified: Irene Davis | Director Elections | Board | WITHHOLD | 5 |
| Ameresco, Inc. | 2026-06-04 | Elect two (2) directors to the Ameresco, Inc. Board of Directors for a three-year term or until their successors are elected and qualified: Claire Hughes-Johnson | Director Elections | Board | WITHHOLD | 5 |
| Ameresco, Inc. | 2026-06-04 | To approve an amendment to Ameresco's 2020 Stock Incentive Plan ("Plan) to increase the number of shares of Ameresco, Inc. Class A Common Stock authorized for issuance under the Plan by 3,200,000 from 5,000,000 to 8,200,000 as described in the Ameresco, Inc. Proxy Statement. | Compensation | Board | AGAINST | 5 |
| Arvinas, Inc. | 2026-06-24 | Election of two Class II directors: Leslie V. Norwalk, Esq. | Director Elections | Board | WITHHOLD | 5 |
| Asana, Inc. | 2026-06-08 | Election of three Class III directors to serve until the 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified: Krista Anderson-Copperman | Director Elections | Board | WITHHOLD | 5 |
| Aspen Aerogels, Inc. | 2026-05-13 | Election of Directors: Donald R. Young | Director Elections | Board | WITHHOLD | 5 |
| Aspen Aerogels, Inc. | 2026-05-13 | Election of Directors: Steven R. Mitchell | Director Elections | Board | WITHHOLD | 5 |
| BeOne Medicines Ltd. | 2026-06-11 | THAT Dr. Alessandro Riva be and is hereby re-elected to serve as a director of the Company for a term extending until completion of the 2027 annual general meeting. | Director Elections | Board | AGAINST | 5 |
| BeOne Medicines Ltd. | 2026-06-11 | THAT Mr. John V. Oyler be and is hereby re-elected to serve as Chairman of the Board of Directors of the Company for a term extending until completion of the 2027 annual general meeting. | Director Elections | Board | AGAINST | 5 |
| BeOne Medicines Ltd. | 2026-06-11 | THAT the Company and its underwriters be and are hereby authorized, in their sole discretion, to allocate to Amgen Inc. ("Amgen"), up to a maximum amount of shares in order to maintain the same shareholding percentage of Amgen (based on the then-outstanding share capital of the Company) before and after the allocation of the corresponding securities issued pursuant to an offering conducted pursuant to the general mandate set forth in Resolution 17 for a period of five years, which period will be subject to an extension on a rolling basis each year. | Capital Structure | Board | AGAINST | 5 |
| BeOne Medicines Ltd. | 2026-06-11 | THAT the Fifth Amended and Restated 2016 Share Option and Incentive Plan be and is hereby approved. | Compensation | Board | AGAINST | 5 |
| BeOne Medicines Ltd. | 2026-06-11 | THAT the granting of a share issue mandate to the Board of Directors to issue, allot or deal with unissued ordinary shares and/or American Depositary Shares ("ADSs") (including any sale or transfer of treasury shares out of treasury) not exceeding 20% of the total number of issued shares of the Company (excluding treasury shares) as of the date of passing of this resolution up to the next annual general meeting of shareholders of the Company be and is hereby approved. | Capital Structure | Board | AGAINST | 5 |
| Cartesian Therapeutics, Inc. | 2026-06-12 | Election of Directors: Michael Singer, M.D., Ph.D. | Director Elections | Board | WITHHOLD | 5 |
| Cartesian Therapeutics, Inc. | 2026-06-12 | Election of Directors: Patrick Zenner, MBA | Director Elections | Board | WITHHOLD | 5 |
| Cartesian Therapeutics, Inc. | 2026-06-12 | Election of Directors: Timothy A. Springer, Ph.D. | Director Elections | Board | WITHHOLD | 5 |
| Cerus Corporation | 2026-06-02 | The approval of an amendment and restatement of the Company's 2024 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance thereunder by 10 million shares and to make certain other changes thereto as described further in the accompanying Proxy Statement. | Compensation | Board | AGAINST | 5 |
| Coherus Oncology, Inc. | 2026-05-29 | To approve a reduction in the exercise price of certain outstanding stock options. | Compensation | Board | AGAINST | 5 |
| Coherus Oncology, Inc. | 2026-05-29 | To approve an increase in the number of shares of our common stock reserved for issuance under the Amended and Restated 2014 Equity Incentive Award Plan. | Compensation | Board | AGAINST | 5 |
| CryoPort, Inc. | 2026-06-05 | To approve an amendment to the Cryoport, Inc. 2018 Omnibus Equity Incentive Plan to increase the number of authorized shares for issuance thereunder from 10,350,000 to 14,625,000; and | Compensation | Board | AGAINST | 5 |
| CuriosityStream Inc. | 2026-05-20 | To approve an amendment to the CuriosityStream Inc. 2020 Omnibus Incentive Plan (the Plan) to increase the number of shares of Common Stock authorized for issuance under the Plan from 10,725,000 shares of Common Stock to 11,725,000 shares of Common Stock. | Compensation | Board | AGAINST | 5 |
| CuriosityStream Inc. | 2026-05-20 | To elect three Class III directors to hold office until the 2029 annual meeting of stockholders or until their respective successors are duly elected and qualified: Matthew Blank | Director Elections | Board | WITHHOLD | 5 |
| Douglas Elliman Inc. | 2026-06-18 | Election of Directors: Mark D. Zeitchick | Director Elections | Board | WITHHOLD | 5 |
| Douglas Elliman Inc. | 2026-06-18 | Election of Directors: Michael S. Liebowitz | Director Elections | Board | WITHHOLD | 5 |
| Emergent BioSolutions Inc. | 2026-04-29 | To approve an amendment to the Emergent BioSolutions Inc Amended and Restated Stock Incentive Plan to increase the number of shares of common stock for the grant of awards under the plan. | Compensation | Board | AGAINST | 5 |
| Entravision Communications Corporation | 2026-05-28 | To approve an amendment and restatement of the Entravision Communications Corporation Amended and Restated 2004 Equity Incentive Plan (the "2004 Plan") to, among other things, increase the number of shares of the Company's Class A common stock authorized for issuance thereunder by 6,000,000 shares. | Compensation | Board | AGAINST | 5 |
| Fate Therapeutics, Inc. | 2026-06-12 | To approve a proposal to amend and restate the Company's 2022 Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder. | Compensation | Board | AGAINST | 5 |
| Ginkgo Bioworks Holdings, Inc. | 2026-06-11 | Election of Directors: Christian Henry | Director Elections | Board | AGAINST | 5 |
| Ginkgo Bioworks Holdings, Inc. | 2026-06-11 | Election of Directors: Harry E. Sloan | Director Elections | Board | AGAINST | 5 |
| Ginkgo Bioworks Holdings, Inc. | 2026-06-11 | Election of Directors: Ross Fubini | Director Elections | Board | AGAINST | 5 |
| Ginkgo Bioworks Holdings, Inc. | 2026-06-11 | Election of Directors: Sri Kosuri | Director Elections | Board | AGAINST | 5 |
| Harmony Gold Mining Co. Ltd. | 2025-11-26 | Approve Implementation Report | Compensation | Board | AGAINST | 5 |
| Heron Therapeutics, Inc. | 2026-06-11 | To approve the amendment and restatement of the Company's 2007 Amended and Restated Equity Incentive Plan, to, among other things, increase the number of shares of common stock authorized for issuance thereunder by an additional 16,560,000 shares. | Compensation | Board | AGAINST | 5 |
| Hyliion Holdings Corp. | 2026-05-19 | Election of Directors: Mary Gustanski | Director Elections | Board | WITHHOLD | 5 |
| Hyliion Holdings Corp. | 2026-05-19 | Election of Directors: Robert Knight, Jr. | Director Elections | Board | WITHHOLD | 5 |
| Hyliion Holdings Corp. | 2026-05-19 | Election of Directors: Rodger Boehm | Director Elections | Board | WITHHOLD | 5 |
| Hyliion Holdings Corp. | 2026-05-19 | To approve an amendment to the Hyliion Holdings Co 2024 Equity Incentive Plan to increase the aggregate number of shares of common stock available for issuance thereunder by 8 million shares. | Compensation | Board | AGAINST | 5 |
| ICICI Bank Limited | 2026-02-25 | Elect Vijayalakshmi Iyer as Director | Director Elections | Board | AGAINST | 5 |
| Inseego Corp. | 2026-06-16 | Elect two directors to serve until the 2029 Annual Meeting of Stockholders.: Jeffrey Tuder | Director Elections | Board | WITHHOLD | 5 |
| Korro Bio, Inc. | 2026-06-10 | Election of two Class I directors, nominated by our board of directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders: Nessan Bermingham | Director Elections | Board | WITHHOLD | 5 |
| Lincoln National Corporation | 2026-05-28 | The approval of an advisory resolution on the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 5 |
| Lucid Diagnostics Inc. | 2026-06-24 | Election of Class B Directors: James L. Cox, M.D. | Director Elections | Board | WITHHOLD | 5 |
| Lucid Diagnostics Inc. | 2026-06-24 | Election of Class B Directors: John R. Palumbo | Director Elections | Board | WITHHOLD | 5 |
| Lucid Diagnostics Inc. | 2026-06-24 | Election of Class B Directors: Ronald M. Sparks | Director Elections | Board | WITHHOLD | 5 |
| MaxCyte, Inc. | 2026-06-17 | To elect the Board's three nominees as identified in the accompanying Proxy Statement as Class II directors: Patrick J. Balthrop | Director Elections | Board | WITHHOLD | 5 |
| NetEase, Inc. | 2026-06-23 | Adopt Consultant Sublimit | Compensation | Board | AGAINST | 5 |
| NetEase, Inc. | 2026-06-23 | Amend and Restate the Amended and Restated 2019 Share Incentive Plan as the Second Amended and Restated 2019 Share Incentive Plan | Compensation | Board | AGAINST | 5 |
| NetEase, Inc. | 2026-06-23 | Approve Issuance of Equity or Equity-Linked Securities without Preemptive Rights | Capital Structure | Board | AGAINST | 5 |
| NetEase, Inc. | 2026-06-23 | Approve PricewaterhouseCoopers Zhong Tian LLP and PricewaterhouseCoopers as Auditors and Authorize Board to Fix Their Remuneration | Audit-related | Board | AGAINST | 5 |
| Neurogene Inc. | 2026-06-03 | Election of Class III Directors for terms expiring in 2029: Robert Baffi, Ph.D. | Director Elections | Board | WITHHOLD | 5 |
| OPKO Health, Inc. | 2026-06-18 | To approve the Company's 2026 Equity Incentive Plan; | Compensation | Board | AGAINST | 5 |
| OPKO Health, Inc. | 2026-06-18 | To elect as directors the eleven nominees named in the attached proxy statement for a term of office expiring at the 2027 annual meeting of stockholders or until their respective successors are duly elected and qualified: Phillip Frost, M.D. | Director Elections | Board | AGAINST | 5 |
| OptimizeRx Corporation | 2026-06-09 | Approval of an amendment to the 2021 Equity Plan to adopt an evergreen provision providing for an automatic annual increase in the shares of Common Stock available for issuance under the 2021 Equity Plan. | Compensation | Board | AGAINST | 5 |
| OptimizeRx Corporation | 2026-06-09 | Election of each of the seven director nominees listed below: Catherine Klema | Director Elections | Board | WITHHOLD | 5 |
| OptimizeRx Corporation | 2026-06-09 | Election of each of the seven director nominees listed below: Lynn O'Connor Vos | Director Elections | Board | WITHHOLD | 5 |
| OptimizeRx Corporation | 2026-06-09 | Election of each of the seven director nominees listed below: Patrick Spangler | Director Elections | Board | WITHHOLD | 5 |
| Organogenesis Holdings Inc. | 2026-06-15 | Election of Directors: Glenn H. Nussdorf | Director Elections | Board | WITHHOLD | 5 |
| Organogenesis Holdings Inc. | 2026-06-15 | Election of Directors: Jon Giacomin | Director Elections | Board | WITHHOLD | 5 |
| Ouster, Inc. | 2026-06-17 | Election of Class II Directors: Angus Pacala | Director Elections | Board | WITHHOLD | 5 |
| Outdoor Holding Company | 2025-08-29 | Incentive Plan Proposal - to approve the Outdoor Holding Company 2025 Long-Term Incentive Plan; | Compensation | Board | AGAINST | 5 |
| Outset Medical, Inc. | 2026-06-04 | Election of Class III Directors: Brent D. Lang | Director Elections | Board | WITHHOLD | 5 |
| Pacific Biosciences of California, Inc. | 2026-06-03 | To approve the amendment of our 2020 Equity Incentive Plan. | Compensation | Board | AGAINST | 5 |
| Personalis, Inc. | 2026-05-12 | Election of Directors: Woodrow A. Myers, Jr., M.D. | Director Elections | Board | WITHHOLD | 5 |
| Phathom Pharmaceuticals, Inc. | 2026-05-19 | To elect three class I directors to hold office until the 2029 Annual Meeting of Stockholders: Steven Basta | Director Elections | Board | WITHHOLD | 5 |
| Pulmonx Corporation | 2026-06-04 | Election of Directors: Georgia Garinois-Melenikiotou | Director Elections | Board | WITHHOLD | 5 |
| Rackspace Technology, Inc. | 2026-06-18 | Approve an amendment to the Company's 2020 Equity Incentive Plan to increase the number of shares of common stock authorized to be issued under the plan. | Compensation | Board | AGAINST | 5 |
| Sana Biotechnology, Inc. | 2026-06-04 | To elect three Class II directors to our Board of Directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders or until his or her respective successor is duly elected and qualified. The nominees for election are: Hans E. Bishop | Director Elections | Board | WITHHOLD | 5 |
| Sibanye Stillwater Ltd. | 2026-05-28 | Approve Financial Assistance in Terms of Sections 44 and 45 of the Companies Act | Capital Structure | Board | AGAINST | 5 |
| Sleep Number Corporation | 2026-05-21 | Approve Amendment to the Sleep Number Corporation 2020 Equity Incentive Plan to increase the number of shares reserved for issuance by 750,000 shares | Compensation | Board | AGAINST | 5 |
| Solid Biosciences Inc. | 2026-06-10 | Election of Class II Directors: Adam Stone | Director Elections | Board | WITHHOLD | 5 |
| Solid Biosciences Inc. | 2026-06-10 | Election of Class II Directors: Clare Kahn | Director Elections | Board | WITHHOLD | 5 |
| Solid Biosciences Inc. | 2026-06-10 | Election of Class II Directors: Lynne Sullivan | Director Elections | Board | WITHHOLD | 5 |
| Standard BioTools Inc. | 2026-06-17 | To approve the Standard BioTools Inc. 2026 Equity Incentive Plan. | Compensation | Board | AGAINST | 5 |
| Stitch Fix, Inc. | 2025-12-11 | Election of Directors: Kofi Amoo-Gottfried | Director Elections | Board | WITHHOLD | 5 |
| Stitch Fix, Inc. | 2025-12-11 | Election of Directors: Timothy Baxter | Director Elections | Board | WITHHOLD | 5 |
| TTEC Holdings, Inc. | 2026-05-21 | The approval of the redomestication of the Company from Delaware to Texas by conversion. | Extraordinary Transactions | Board | AGAINST | 5 |
| Taysha Gene Therapies, Inc. | 2026-06-01 | To elect the Board's Class III Director nominees, Sean P. Nolan and Laura Sepp-Lorenzino, Ph.D. to the Board of Directors to hold office until the 2029 Annual Meeting of Stockholders: Sean P. Nolan | Director Elections | Board | WITHHOLD | 5 |
| Teads Holding Co. | 2026-05-14 | Election of Directors To be elected for terms expiring in 2029: Arne Wolter | Director Elections | Board | WITHHOLD | 5 |
| Tectonic Therapeutic, Inc. | 2026-06-08 | Election of Directors: Timothy A. Springer, Ph.D. | Director Elections | Board | WITHHOLD | 5 |
← Previous Page 8 of 27 Next →
← Back to Guggenheim 2025-2026 overview
Built 2026-10-11 from SEC Form N-PX filings.